| 1. | Murawala, P., Tirmale, A., Shiras, A. and Prasad, B. L. In situ synthesized BSA capped gold nanoparticles: Effective carrier of anticancer drug Methotrexate to MCF-7 breast cancer cells. Materials Science & Engineering. C, Materials For Biological Applications. 2014. 34, 158-167. [PubMed] |
2. | Rani, S. B., Rathod, S. S., Karthik, S., Kaur, N., Muzumdar, D. and Shiras, A. S. MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro-oncology. 2013. 15, 1302-1316. [PubMed] | 3. | Gupta, M. K., Polisetty, R. V., Ramamoorthy, K., Tiwary, S., Kaur, N., Uppin, M. S., Shiras, A. and Sirdeshmukh, R. Secretome analysis of Glioblastoma cell line--HNGC-2. Molecular BioSystems. 2013. 9, 1390-1400. [PubMed] | 4. | Kaur, N., Chettiar, S., Rathod, S., Rath, P., Muzumdar, D., Shaikh, M. L. and Shiras, A. Wnt3a mediated activation of Wnt/beta-catenin signaling promotes tumor progression in glioblastoma. Molecular and Cellular Neurosciences. 2013. 54, 44-57. [PubMed] | 5. | Polisetty, R. V., Gupta, M. K., Nair, S. C., Ramamoorthy, K., Tiwary, S., Shiras, A., Chandak, G. R. and Sirdeshmukh, R. Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins. Journal of Proteomics. 2011. 74, 1918-1925. [PubMed] | 6. | Mruthyunjaya, S., Rumma, M., Ravibhushan, G., Anjali, S. and Padma, S. c-Jun/AP-1 transcription factor regulates laminin-1-induced neurite outgrowth in human bone marrow mesenchymal stem cells: role of multiple signaling pathways. FEBS Letters. 2011. 585, 1915-1922. [PubMed] | 7. | Das, G., Shiras, A., Shanmuganandam, K. and Shastry, P. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Molecular Carcinogenesis. 2011. 50, 412-423. [PubMed] | 8. | Joshi-Navare, K., Shiras, A. and Prabhune, A. Differentiation-inducing ability of sophorolipids of oleic and linoleic acids using a glioma cell line. Biotechnology Journal. 2011. 6, 509-512. [PubMed] | 9. | Venkatpurwar, V., Shiras, A. and Pokharkar, V. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study. International Journal of Pharmaceutics. 2011. 409, 314-320. [PubMed] | 10. | Rajendran, G., Shanmuganandam, K., Bendre, A., Muzumdar, D., Goel, A. and Shiras, A. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas. Journal of Neuro-oncology. 2011. 104, 483-494. [PubMed] | 11. | Dhar, S., Mali, V., Bodhankar, S., Shiras, A., Prasad, B. L. and Pokharkar, V. Biocompatible gellan gum-reduced gold nanoparticles: cellular uptake and subacute oral toxicity studies. Journal of Applied Toxicology : JAT. 2011. 31, 411-420. [PubMed] | 12. | Dhar, S., Reddy, E. M., Prabhune, A., Pokharkar, V., Shiras, A. and Prasad, B. L. Cytotoxicity of sophorolipid-gellan gum-gold nanoparticle conjugates and their doxorubicin loaded derivatives towards human glioma and human glioma stem cell lines. Nanoscale. 2011. 3, 575-580. [PubMed] | 13. | Reddy, E. M., Chettiar, S. T., Kaur, N., Shepal, V. and Shiras, A. Dlxin-1, a MAGE family protein, induces accelerated neurite outgrowth and cell survival by enhanced and early activation of MEK and Akt signalling pathways in PC12 cells. Experimental Cell Research. 2010. 316, 2220-2236. [PubMed] | 14. | Mruthyunjaya, S., Manchanda, R., Godbole, R., Pujari, R., Shiras, A. and Shastry, P. Laminin-1 induces neurite outgrowth in human mesenchymal stem cells in serum/differentiation factors-free conditions through activation of FAK-MEK/ERK signaling pathways. Biochemical and Biophysical Research Communications. 2010. 391, 43-48. [PubMed] | 15. | Dhar, S., Reddy, E. M., Shiras, A., Pokharkar, V. and Prasad, B. L. Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chemistry. 2008. 14, 10244-10250. [PubMed] | 16. | Sudheerkumar, P., Shiras, A., Das, G., Jagtap, J. C., Prasad, V. and Shastry, P. Independent activation of Akt and NF-kappaB pathways and their role in resistance to TNF-alpha mediated cytotoxicity in gliomas. Molecular Carcinogenesis. 2008. 47, 126-136. [PubMed] | 17. | Kumar, P. S., Shiras, A., Das, G., Jagtap, J. C., Prasad, V. and Shastry, P. Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells. Molecular Cancer. 2007. 6, 42. [PubMed] | 18. | Shiras, A., Chettiar, S. T., Shepal, V., Rajendran, G., Prasad, G. R. and Shastry, P. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells. 2007. 25, 1478-1489. [PubMed] | 19. | Shiras, A., Bhosale, A., Shepal, V., Shukla, R., Baburao, V. S., Prabhakara, K. and Shastry, P. A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers. Neoplasia. 2003. 5, 520-532. [PubMed] | 20. | Shiras, A., Bhosale, A., Patekar, A., Shepal, V. and Shastry, P. Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines. Clinical & Experimental Metastasis. 2002. 19, 445-455. [PubMed] |